Radiation Impact on Thromboembolic Events
The aim of the present study is to determine the frequency and to identify main risk factors for venous thromboembolism of venous thromboembolic complications in a population of cancer patients treated with a curative intent by ionizing radiation.
Malignant Neoplasm
BIOLOGICAL: Biomarkers assays
Venous Thromboembolism event, All venous thromboembolism, whether symptomatic or discovered incidentally, objectified (CT angiography, lung scintigraphy, venous Doppler) between J1 of radiation treatment, up to 6 months following discontinuation of radiation treatment, 6 months
Dosage of D-dimer, 6 months|C-reactive protein, 6 months|Complete blood count, 6 months|Time of occurrence of VTE, Time of occurrence of VTE, 6 months|Symptomatic VTE, Symptomatic VTE., 6 months
The aim of the present study is to determine the frequency and to identify main risk factors for venous thromboembolism of venous thromboembolic complications in a population of cancer patients treated with a curative intent by ionizing radiation.